Robert Parks mostly deals with Virology, Antibody, Immune system, Immunology and Epitope. Robert Parks is interested in Vaccination, which is a branch of Virology. His Vaccination research includes themes of Mutation, Viral evolution and Zika virus.
Robert Parks studies Antibody, namely Neutralization. His studies in Immune system integrate themes in fields like Virus and Peptide sequence. As part of one scientific family, Robert Parks deals mainly with the area of Immunology, narrowing it down to issues related to the Binding site, and often Phylogenetics, Neutralization test, Site specificity, Broadly neutralizing antibody and Immunotherapy.
His primary scientific interests are in Virology, Antibody, Epitope, Immune system and Immunology. Robert Parks has researched Virology in several fields, including Immunization and Immunogenicity. His Antibody research includes elements of Molecular biology and Antigen.
The concepts of his Epitope study are interwoven with issues in Peptide sequence, Immunogen and Glycan. His Immune system research is multidisciplinary, incorporating perspectives in Protein structure and Lineage. His Virus research incorporates elements of Viral evolution and Heterologous.
The scientist’s investigation covers issues in Antibody, Virology, Immune system, Immunization and Vaccination. His Antibody research focuses on Neutralization in particular. His Neutralization study incorporates themes from Protein subunit, Trogocytosis and Epitope mapping, Monoclonal antibody.
His Virology research is multidisciplinary, incorporating elements of Epitope, B cell and Glycan. Immune system is a subfield of Immunology that Robert Parks investigates. His study looks at the intersection of Immunization and topics like Messenger RNA with Recombinant DNA and Nucleoside.
His scientific interests lie mostly in Antibody, Virology, Ectodomain, Virus and Protein domain. His Antibody research includes themes of CD8 and Immune system. Virology is closely attributed to Messenger RNA in his research.
His Ectodomain study integrates concerns from other disciplines, such as Mutation rate and Cell biology. His studies in Virus integrate themes in fields like In vitro, Fc receptor, Cytokine and In vivo. His work deals with themes such as Plasma protein binding, Biophysics, Gp41, Viral entry and Allosteric regulation, which intersect with Protein domain.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Hua-Xin Liao;Rebecca Lynch;Tongqing Zhou;Feng Gao;Feng Gao.
Nature (2013)
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
Georgia D. Tomaras;Nicole L. Yates;Pinghuang Liu;Li Qin.
Journal of Virology (2008)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi;Michael J. Hogan;Rebecca S. Pelc;Hiromi Muramatsu.
Nature (2017)
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan.
Immunity (2013)
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
Georgia D. Tomaras;Guido Ferrari;Xiaoying Shen;S. Munir Alam.
Proceedings of the National Academy of Sciences of the United States of America (2013)
Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers.
Olivier Lambotte;Guido Ferrari;Christiane Moog;Nicole L Yates.
AIDS (2009)
Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16
Marie Pancera;Syed Shahzad-Ul-Hussan;Nicole A. Doria-Rose;Jason S. McLellan.
Nature Structural & Molecular Biology (2013)
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.
Jinghe Huang;Byong H. Kang;Elise Ishida;Tongqing Zhou.
Immunity (2016)
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.
Sampa Santra;Hua-Xin Liao;Ruijin Zhang;Mark Muldoon.
Nature Medicine (2010)
Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection
Susan Zolla-Pazner;Allan DeCamp;Peter B. Gilbert;Constance Williams.
PLOS ONE (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Duke University
Duke University
Jinan University
Duke University
Duke University
Duke University
Duke University
Duke University
Beth Israel Deaconess Medical Center
Boston University
University of Toronto
University of Waterloo
University of Konstanz
Agricultural University of Athens
National Institute of Standards and Technology
Amgen (United States)
University of Oulu
North Carolina State University
University of Siena
Spanish National Research Council
Karolinska Institute
Bangor University
Harvard Medical School
Radboud University Nijmegen
Indiana University
Stanford University